Detalhe da pesquisa
1.
Immunological effects of nivolumab immunotherapy in patients with oral cavity squamous cell carcinoma.
BMC Cancer
; 20(1): 229, 2020 Mar 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-32183719
2.
High-Fat Diet Alters Immunogenic Properties of Circulating and Adipose Tissue-Associated Myeloid-Derived CD45+DDR2+ Cells.
Mediators Inflamm
; 2019: 1648614, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31015794
3.
Transient immunological and clinical effectiveness of treating mice bearing premalignant oral lesions with PD-1 antibodies.
Int J Cancer
; 140(7): 1609-1619, 2017 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27914100
4.
Cancer Immunology with a Focus on Understudied Cancers as Targets for Immunotherapy.
Int J Mol Sci
; 18(1)2017 Jan 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28085027
5.
Treatment to sustain a Th17-type phenotype to prevent skewing toward Treg and to limit premalignant lesion progression to cancer.
Int J Cancer
; 138(10): 2487-98, 2016 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26756968
6.
Restoration of Immune Responsiveness to Glioma by Vaccination of Mice with Established Brain Gliomas with a Semi-Allogeneic Vaccine.
Int J Mol Sci
; 17(9)2016 Sep 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27598146
7.
Characterization of the evolution of immune phenotype during the development and progression of squamous cell carcinoma of the head and neck.
Cancer Immunol Immunother
; 61(6): 927-39, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22116344
8.
Immunological modulation by 1α,25-dihydroxyvitamin D3 in patients with squamous cell carcinoma of the head and neck.
Cytokine
; 58(3): 448-54, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22450225
9.
Immunotherapy for head and neck cancer: advances and deficiencies.
Anticancer Drugs
; 22(7): 674-81, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21037467
10.
Regulatory T-cell trafficking: from thymic development to tumor-induced immune suppression.
Crit Rev Immunol
; 30(5): 435-47, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-21083525
11.
NK-dependent increases in CCL22 secretion selectively recruits regulatory T cells to the tumor microenvironment.
J Immunol
; 182(5): 2753-65, 2009 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19234170
12.
Neoadjuvant presurgical PD-1 inhibition in oral cavity squamous cell carcinoma.
Cell Rep Med
; 2(10): 100426, 2021 10 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34755137
13.
NK depletion results in increased CCL22 secretion and Treg levels in Lewis lung carcinoma via the accumulation of CCL22-secreting CD11b+CD11c+ cells.
Int J Cancer
; 127(11): 2598-611, 2010 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20198623
14.
Tumors induce the formation of suppressor endothelial cells in vivo.
Cancer Immunol Immunother
; 59(2): 267-77, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19669642
15.
1alpha,25-Dihydroxyvitamin D(3) to skew intratumoral levels of immune inhibitory CD34(+) progenitor cells into dendritic cells.
Otolaryngol Head Neck Surg
; 140(2): 235-40, 2009 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19201295
16.
Reduced Expression of Immune Mediators by T-Cell Subpopulations of Combat-Exposed Veterans With Post-Traumatic Stress Disorder.
Front Psychiatry
; 10: 693, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31620037
17.
Influence of vitamin D on cancer risk and treatment: Why the variability?
Trends Cancer Res
; 13: 43-53, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30369773
18.
Role of IL-23 signaling in the progression of premalignant oral lesions to cancer.
PLoS One
; 13(4): e0196034, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29664967
19.
Autocrine motility-stimulatory pathways of oral premalignant lesion cells.
Clin Exp Metastasis
; 24(2): 131-9, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17370039
20.
Redirecting the focus of cancer immunotherapy to premalignant conditions.
Cancer Lett
; 391: 83-88, 2017 04 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28130162